NCT00465647View on ClinicalTrials.gov

An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

April 30, 2010

Conditions
Postoperative Pain
Interventions
DRUG

Hydromorphone

Oral hydromorphone solution dosed every 6 hours up to 9 doses. Dose is determined based on the expected weight range for each age group.

Trial Locations (14)

27710

Duke University Medical Center, Durham

33136

Jackson Memorial Hospital, Miami

44308

Children's Hospital Medical Center of Akron, Akron

52242

University of Iowa Hospitals and Clinics, Iowa City

63104

Saint Louis University - Department of Neurology and Psychiatry, St Louis

72202

Arkansas Children's Hospital, Little Rock

75235

Children's Medical Center, Dallas

77030

Texas Children's Hospital / Baylor College of Medicine, Houston

The University of Texas, Health Sciences Center at Houston, Houston

80218

The Children's Hospital, Aurora

92868

Children's Hospital of Orange County - Pediatric Subspecialty, Orange

94305

Stanford University Medical Center, Stanford

06510

Yale-New Haven Children's Hospital, New Haven

27599-7221

The University of North Carolina - CH, Chapel Hill

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT00465647 - An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain | Biotech Hunter | Biotech Hunter